+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


UK Ophthalmic laser Market 2019-2025

  • ID: 5116614
  • Report
  • February 2020
  • Region: United Kingdom
  • Orion Market Research Private Limited
until Dec 31st 2021


  • Bausch & Lomb, Inc.
  • Boston Scientific Corp.
  • Carl Zeiss Meditec AG
  • IPG Photonics Corp.
  • Johnson & Johnson
  • NIDEK Co., Ltd.
UK Ophthalmic laser Market Size, Share & Trends Analysis Report by Type (Excimer Laser, Femtosecond Laser, Cyclodiode Laser, Nd: YAG Laser, Selective-Laser-Trabeculoplasty (SLT) Laser and Others), by Applications (Cataract Surgery, Glaucoma Surgery, Diabetic Retinopathy, Refractive Surgery, Age-Related Macular Degeneration (AMD), Cornea Transplant Surgery, and Others), and by End-User (Hospital, Clinic, and Ambulatory Surgical Center) Forecast Period 2019-2025.

UK ophthalmic laser market is growing at a CAGR of around 5.9% during the forecast period. As per the National Health System (NHS) UK, in UK, in 2018, there were almost 2 million people living with sight loss. Of these, around 360,000 are registered as blind or partially sighted. As per the National Center for Biotechnology Information (NCBI), in 2018, the leading cause of blindness is age-related macular degeneration, which affects more than 0.6 million people every year in UK. Glaucoma and cataract are other prevalent eye problems in the country.

Sight loss and blindness from age-related macular degeneration (AMD), cataract, diabetic retinopathy, glaucoma and under-corrected refractive error are estimated to affect 1.93 million people in UK. As per the report of National Healthcare System in 2017, the mean waiting time for having a cataract surgery in the country is a period of 73 days. Thus, there is a large scope for the UK ophthalmic laser market owing to the presence of targeted pool of patients.

The World Health Organization’s Vision 2020 program to eliminate preventable blindness by 2020 provides a strategic context for vision care service development. In 2017, UK stakeholders have developed a UK Vision Strategy inspired by the WHO’s initiative. The Department of Health is committed to supporting the aims of the UK Vision Strategy within the context of a locally commissioned service. The UK Vision Strategy aims to improve the eye health of the people of UKand to eliminate avoidable sight loss and deliver excellent support to those with visual impairment. In 2018, the number of people diagnosed with diabetes in UK was 3.5 million. These represent 6% of the UK population or 1 in every 16 people having diabetes.

However, there exist various new technologies in UK in terms of ophthalmology such as Astigmatic Keratotomy (AK), Automated Lamellar Keratoplasty (ALK), and Photorefractive Keratectomy (PRK) among others. Ophthalmic medical practitioners play only a minor role in ophthalmic laser surgery due to a very small number. The average cost of laser eye surgery in the UK is between $1,304 and $3,914 per eye. Irrespective of the cost of laser surgery, the increasing prevalence of eye problems will foster the growth of UK ophthalmic laser market.

Research Methodology:

The market study of the UK Ophthalmic laser market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. The research team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables the analyst to derive the closest possible figures without any major deviations in the actual number. The analysts try to contact as many executives, managers, key opinion leaders, and industry experts. Primary research brings authenticity to the reports.

Secondary Sources Include:
  • Financial reports of companies involved in the market.
  • Whitepapers, research-papers, and news blogs.
  • Company websites and their product catalog.
The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation:

1. UK Ophthalmic laser Market Research and Analysis by Type
2. UK Ophthalmic laser Market Research and Analysis by Application
3. UK Ophthalmic laser Market Research and Analysis by End-User

The Report Covers:
  • Comprehensive Research Methodology of the UK Ophthalmic laser market.
  • This report also includes a detailed and extensive market overview with key analyst insights.
  • An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.
  • Analysis of regional regulations and other government policies impacting the UK Ophthalmic laser market.
  • Insights about market determinants which are stimulating the UK Ophthalmic laser market.
  • Detailed and extensive market segments with regional distribution of forecasted revenues.
  • Extensive profiles and recent developments of market players.
Note: Product cover images may vary from those shown

A selection of companies mentioned in this report includes:

  • Bausch & Lomb, Inc.
  • Boston Scientific Corp.
  • Carl Zeiss Meditec AG
  • IPG Photonics Corp.
  • Johnson & Johnson
  • NIDEK Co., Ltd.
  • Novartis International AG
  • Ziemer Ophthalmic Systems AG
Note: Product cover images may vary from those shown